Singapore Hepatology
Conference 2024

26 July to 27 July 2024

8:30 am to 5:00 pm (SGT)

SHC 2024

26 July to 27 July 2024

8:30 am to 5.00 pm (SGT)

REGISTRATION FOR The Combined GIHep & Singapore Hepatology Conference includes SHC 2024!

We are committed to delivering Short, Focused Clinical Updates on all aspects of Hepatology from the World’s leading experts.

REGISTER HERE for the Combined Conference

To access SHC -e Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)


SHC 2024 Preliminary Draft Scientific Programme

July, 2024


Programme Time (SGT)
Welcome Remarks by the Conference Chairman and SHC partners 08:30 – 8:40
Chronic Hepatitis B symposium
Advances in HBV Cure 2024
Prof. Man Fung Yuen, Hong Kong View Bio
08:40 – 09:00
New guidelines for CHB
Prof. Jidong Jia, China View Bio
09:00 – 09:20
Debate: Should treatment be expanded
Yes: Prof. Man Fung Yuen, Hong Kong View Bio
No: Prof. Heiner Wedemeyer, Germany View Bio
09:20 – 09:40
Stopping nucleoside analogue therapy: worth the risk?
Prof. Harry Janssen, Netherlands View Bio
09:40- 10:00
Update on management of HBV flares
Prof. Teerha Piratvisuth, Thailand View Bio
10:00 – 10:20
Round table discussion/Case discussion 10:20 – 10:40
Tea Break 10:40 – 11:00
Delta Cure Symposium
What is the prevalence of delta hepatitis and how do you diagnose it
Prof. Pei Jer Chen, Taiwan View Bio
11:00 – 11:20
What is delta cure and how to achieve it?
Prof. Pietro Lampertico, Italy View Bio
11:20 – 11:40
Treatment options for delta cirrhosis
Prof. Heiner Wedemeyer, Germany View Bio
11:40- 12:00
Round table/case discussion 12:00- 12:20
Lunch Symposium 12:20 – 14:00
NASH Symposium
NAFLD, MAFLD, MASLD – practical implications of a name change.
Dr. George Goh, Singapore
14:00 – 14:20
Community screening and care pathways in Fatty Liver Disease
Prof. Wah Kheong Chan, Malaysia View Bio
14:20 – 14:40
Selecting patients for pharmacological treatment
Prof. Sven Francque, Belgium
14:40 – 15:00
Debate: Vitamin E for NAFLD
Yes: Prof. Arun Sanyal View Bio
No: Prof. Vincent Wong View Bio
15:00 – 15:20
Pearls and pitfalls on how to use GLP1 agonists
Dr. Mark Muthiah, Singapore View Bio
15:20 – 15:40
Summary of the inaugural Singapore NASH workshop
Prof. Arun Sanyal View Bio
15:40 – 16:00
Round table/case discussion 16:00 – 16:20
Tea Symposium 16:20 – 17:20
Fireside Chat with Hepatology experts: learning from the leaders
Featuring Rajender Reddy, Guadalupe Garcia-Tsao & Arun Sanyal 17:20 – 18:00
Dinner Symposium 18:00 – 20:00
End of day 1

July, 2024


Programme Time (SGT)
HCC Symposium
Hepatocellular surveillance: Barriers, gaps and new strategies
Dr. Ken Liu, Australia  View Bio
09:00 – 09:20
Role of non-invasive tests in NASH and HCC risk 09:20 – 09:40
Debate: Adjuvant therapy for HCC Cure
Yes: Prof. Pierce Chow, Singapore
View Bio
No: Prof. Glenn Bonney, Singapore View Bio
09:40 –10:00
Updates in systemic therapy for HCC: the way forward
Dr. Cheng Ean Chee, Singapore View Bio
10:00 – 10:20
Round-table /case discussion 10:20 – 10:40
Tea Break 10:40 – 11:00
Other Liver Diseases 
The forgotten disease: Alcoholic liver disease & MetALD
Prof. Ajay Duseja, India View Bio
11:00 – 11:20
Difficult to treat autoimmune hepatitis
Prof. Atsushi Tanaka, Japan
11:20 – 11:40
Biliary cirrhosis and sclerosing cholangitis: Update
Prof. Atsushi Tanaka, Japan
11:40- 12:00
Round table/Case discussion 12:00- 12:20
Lunch Symposium 12:40– 14:00
Advanced Liver Disease Management for the practising gastroenterologist/hepatologist
Optimising management of portal hypertension
Prof. Guadalupe Garcia Tsao, USA View Bio
14:00 – 14:20
Acute and acute on chronic liver failure
Prof. Ajay Duseja, India View Bio
14:20 – 14:40
Preventing complications of advanced liver disease
Dr. Ken Liu, Australia  View Bio
14:40 – 15:00
When to refer patients for liver transplantation
Dr. Ruveena Bhavani Rajaram, Malaysia
15:00 – 15:20
Futility in liver transplantation
Prof. Rajender Reddy, USA View Bio
15:20 – 15:40
Round table/cases discussion 15:40 – 16:00
Meet the Professor Tea Symposium 16:00– 17:00
Closing comments from the Chairman 17:00 – 17:10

Who Should Attend?

The SHC 2024 programme is designed for clinicians, scientists nurse practitioners, pharmacists, from Asia, the Indian Sub-continent, Australia and New Zealand, to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field  of hepatology.

Our Attendees Include:

  • Hepatology experts.
  • Clinical, basic, and translational researchers.
  • Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
  • Primary care physicians.
  • Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
  • Trainees, and students in the disciplines listed above.

REGISTER HERE for the Combined Conference

To access SHC -e Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)

Call for Abstracts

25 to 28 July 2024

8.30 am to 5.00 pm (SGT)

We invite all interested parties to present their research papers. Click Below on Abstracts and Posters for further information.

Abstracts will be reviewed by the Abstract Selection Committee and accepted submissions will be posted on Abstract & Poster Gallery in our website and in the Poster Hall.

The Abstract/Poster information and submission page will be open shortly.